Mechanisms That Matter: CKD and T2D

Mechanisms That Matter: chronic kidney disease (CKD) and type 2 diabetes (T2D) is organized by Medscape, LLC.

CME / ABIM MOC / CE Released: 12/23/2020
Valid for credit through: 12/23/2021

Accreditation:
For Physicians
Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

Goal Statement:
The goal of this activity is to increase awareness of the pathophysiology of CKD in T2D, as well as to update healthcare providers on the latest clinical trial data on CKD in T2D.

Learning Objectives:
Upon completion of this activity, participants will:
• Have increased knowledge regarding the
? Pathophysiology of CKD development and progression in patients with T2D
? Evidence supporting the role of inflammation and fibrosis as a mechanism of mineralocorticoid receptor (MR) over activation and CKD progression
? Potential role of MR antagonists (MRAs) in delaying progression of CKD in patients with T2D